CAMZYOS

This brand name is authorized in United States. It is also authorized in Austria, Canada, Cyprus, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Poland, Romania, UK.

Active ingredients

The drug CAMZYOS contains one active pharmaceutical ingredient (API):

1	Mavacamten UNII QX45B99R3J - MAVACAMTEN
	Mavacamten is a selective, allosteric, and reversible cardiac myosin inhibitor. Mavacamten modulates the number of myosin heads that can enter power-generating states, thus reducing (or in HCM normalizing) the probability of force-producing systolic and residual diastolic cross-bridge formation. Mavacamten also shifts the overall myosin population towards an energy-sparing, but recruitable, super-relaxed state. In HCM patients, cardiac myosin inhibition with mavacamten normalises contractility, reduces dynamic LVOT obstruction, and improves cardiac filling pressures.
	Read more about Mavacamten

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CAMZYOS Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01EB24		C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02532549, 02532557, 02532565, 02532573
EE	Ravimiamet	3044360, 3044371, 3044382, 3044393, 3044405, 3044416, 3044427, 3044438
FI	Lääkealan turvallisuus- ja kehittämiskeskus	435425, 542552, 562701, 596628
FR	Base de données publique des médicaments	63820570, 67684776, 68030434, 68577204
IL	מִשְׂרַד הַבְּרִיאוּת	9200, 9201, 9202, 9203
IT	Agenzia del Farmaco	050755014, 050755026, 050755038, 050755040, 050755053, 050755065, 050755077, 050755089
LT	Valstybinė vaistų kontrolės tarnyba	1097307, 1097308, 1097309, 1097310, 1097311, 1097312, 1097313, 1097314
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69744001, W69745001, W69746001, W69747001
US	FDA, National Drug Code	73625-111, 73625-112, 73625-113, 73625-114